EUDA Health Holdings Limited

NASDAQ:EUDA

Medical - Care Facilities

Healthcare
$17.70 +14.19%

+$2.20 today

Market cap
$53.00M
Beta
0.59
P/E (TTM)
-7.9
EPS (TTM)
-$1.79
52W Low $5.26High $71.20

Volume 0.04M

Average 0.02M

EUDA Accounts Receivables

Cash effect of the change in amounts owed by customers; growing receivables consume cash.

EUDA Health Holdings LimitedNASDAQ: EUDA

Accounts Receivables · Q2 FY2026 · quarter ended Jun 2026

Accounts receivables grows, but more slowly than its trailing trend

Q2 FY2026 accounts receivables of $253.68K (cash outflow) rose 95.6% year over year, behind the +121.4% change in trailing-twelve-month accounts receivables. Sequentially, it rose 0.0% from the prior quarter. Over 3 fiscal years it compounded at -1.5% a year.

Context

  • Accounts receivables amounted to 2.4% of revenue in FY2025, up 0.4 pp from a year earlier.
  • Accounts receivables increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from +95.6% toward the trailing-twelve-month pace of +121.4%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
-$253.68K+0.0% QoQ
Last fiscal yearDec 2025
-$166.99K-302.8% YoY
LTMJun 2026
-$506.64K+121.4% YoY
Accounts Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+95.6%——
1 year-302.8%——
3-year CAGR-1.5%——
5-year CAGR——
10-year CAGR——

Accounts Receivables history

USD · from the cash flow

Latest · FY2025
(166.99K) USD
Year-over-year change
-302.8%

Accounts Receivables vs competitors

How EUDA compares with its peers on the latest reported figures

  • Peers report in different currencies, so accounts receivables is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +121.4% is the 3rd highest of 8, against a peer median of -27.6%.
  • Accounts receivables amounts to 4.2% of revenue for EUDA, versus a peer median of 10.9%.
EUDA Competitors
Accounts Receivables for EUDA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
AMWLAmerican Well CorporationLTM Mar 2026$9.9M USD+307.0%—4.2%
FONRFONAR CorporationLTM Mar 2026$7.22M USD-27.6%+17.3%6.9%
DTILPrecision BioSciences, Inc.LTM Mar 2026$5.47M USD-147.5%—12.1%
HYPRHyperfine, Inc.LTM Mar 2026$1.47M USD+242.9%—9.6%
ATYRaTyr Pharma, Inc.LTM Mar 2026$511K USD-26.6%—268.9%
EUDAEUDA Health Holdings LimitedLTM Jun 2026$506.64K USD+121.4%-1.5%4.2%
ZTEKZentek Ltd.LTM Mar 2026CA$144.66K CAD-84.3%—87.1%
GUTSFractyl Health, Inc. Common StockLTM Mar 2026$0 USD-100.0%——
Peer median (excluding EUDA) —-27.6%+17.3%10.9%

Competitors are the stored peer set for EUDA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income900.4K(24.95M)(8.44M)(17.6M)(2.77M)
Depreciation & Amortization264.1K172.02K119.35K173.22K406.48K
Deferred Income Tax(27.68K)(48.23K)0(4.38K)4.38K
Stock-Based Compensation00000
Change in Working Capital1.18M1.12M531.2K194.93K(230.03K)
Accounts Receivables(263.95K)(174.82K)(32.97K)82.35K(166.99K)
Inventory03.69M0(126.27K)45.43K
Accounts Payables1.38M(1.13M)1.27K15.99K(12.95K)
Other Working Capital68.04K(1.27M)562.89K222.86K(95.52K)
Other Non-Cash Items(1.87M)22.18M4.87M15.21M160.35K
Operating Cash Flow443.92K(1.53M)(2.92M)(2.03M)(2.43M)
Capital Expenditures(1.96K)(18.14K)(5)(116.03K)(104.45K)
Acquisitions (Net)(354.23K)(3.41K)016.3K0
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities(355.08K)(246.66K)5(48.03K)(27.19K)
Investing Cash Flow(356.18K)(268.21K)0(147.77K)(104.45K)
Debt Repayment(6.69K)1.4M1.44M2.16M2.22M
Common Stock Issued01.1M790K50K100K
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(161.69K)(9.47K)121.88K115.14K234.46K
Financing Cash Flow(168.37K)2.49M2.35M2.32M2.55M
Effect of Forex Changes19.87K(99.42K)(21.53K)(101.66K)88.49K
Net Change in Cash(60.77K)594.49K(586.93K)40.05K107.54K
Free Cash Flow441.96K(1.54M)(2.92M)(2.15M)(2.53M)

EUDA Health Holdings Limited

NASDAQ:EUDA

Intrinsic Alpha fair value

Locked

Current Price

$17.70

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.